NCT03527459

Brief Summary

The purpose of this project is to evaluate a set of interventions derived from a theory of suicide that supplements a clinical program and compare their effects on outcomes to the outcomes of the unsupplemented program. This study proposes to evaluate the effect of these interventions on reducing specific negative cognitions associated with depression and suicide ideation in an intensive outpatient program for suicidal youth (Suicide Prevention and Resilience at Children's, SPARC).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
123

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 14, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 2, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 17, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

November 1, 2019

Status Verified

October 1, 2019

Enrollment Period

1.3 years

First QC Date

May 2, 2018

Last Update Submit

October 30, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Interpersonal Needs Questionnaire (INQ) (Van Orden et al., 2012)

    change in perceived burdensomeness

    through program completion, an average of 6 weeks

  • Concise Health Risk Tracking Self Report (CHRT-SR) (Trivedi et al., 2011)

    suicide ideation (self-report)

    through program completion, an average of 6 weeks

Secondary Outcomes (5)

  • Quick Inventory of Depressive Symptomatology - Adolescent Version Self-Report (QIDS-A-SR-16) (Bernstein et al., 2010)

    through program completion, an average of 6 weeks

  • Interpersonal Needs Questionnaire (INQ) (Van Orden et al., 2012)

    1 month after program completion

  • Concise Health Risk Tracking Self Report (CHRT-SR) (Trivedi et al., 2011)

    1 month after program completion

  • Quick Inventory of Depressive Symptomatology - Adolescent Version Self-Report (QIDS-A-SR-16) (Bernstein et al., 2010)

    1 month after program completion

  • Concise Health Risk Tracking Self Report (CHRT-SR)

    between program completion, an average of 6 weeks, and 1 month after program completion

Study Arms (2)

SPARC A

ACTIVE COMPARATOR

SPARC A is an existing clinical program which has a general focus on negative cognitions.

Behavioral: SPARC A

SPARC B

EXPERIMENTAL

SPARC B includes all aspects of the SPARC A clinical program, but targets negative cognitions of perceived burdensomeness in some sessions.

Behavioral: SPARC B

Interventions

SPARC BBEHAVIORAL

SPARC B includes all aspects of the SPARC A clinical program, as well as targeting negative cognitions of perceived burdensomeness.

SPARC B
SPARC ABEHAVIORAL

SPARC A is an existing clinical program with a general focus on negative cognitions.

SPARC A

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • adolescents, ages 12 - 17
  • enrolled in the SPARC program at Children's Medical Center of Dallas
  • completed at least 5 SPARC group therapy sessions

You may not qualify if:

  • adolescents who have previously received treatment in the control arm of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Medical Center

Dallas, Texas, 75235, United States

Location

Related Publications (3)

  • Bernstein IH, Rush AJ, Trivedi MH, Hughes CW, Macleod L, Witte BP, Jain S, Mayes TL, Emslie GJ. Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents. Int J Methods Psychiatr Res. 2010 Dec;19(4):185-94. doi: 10.1002/mpr.321.

    PMID: 20683845BACKGROUND
  • Trivedi MH, Wisniewski SR, Morris DW, Fava M, Gollan JK, Warden D, Nierenberg AA, Gaynes BN, Husain MM, Luther JF, Zisook S, Rush AJ. Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry. 2011 Jun;72(6):757-64. doi: 10.4088/JCP.11m06837.

    PMID: 21733476BACKGROUND
  • Van Orden KA, Cukrowicz KC, Witte TK, Joiner TE. Thwarted belongingness and perceived burdensomeness: construct validity and psychometric properties of the Interpersonal Needs Questionnaire. Psychol Assess. 2012 Mar;24(1):197-215. doi: 10.1037/a0025358. Epub 2011 Sep 19.

    PMID: 21928908BACKGROUND

MeSH Terms

Conditions

Suicidal IdeationDepression

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Sunita M. Stewart, PhD

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants are masked as to the treatment arm to which they are assigned. Care providers in the control arm are masked to the interventions being tested in the experimental arm, so as to not inadvertently deliver aspects of SPARC B intervention to the SPARC A group. The outcomes assessor is not collecting primary outcome data, which is self-reported via online survey.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Half of the clients in the SPARC clinical program are enrolled into either the original program or SPARC B (which will overlap significantly with SPARC A but targets in some sessions specific negative cognitions of perceived burdensomeness). The program is already structured so that each patient consistently attends either a morning or an afternoon track, with different therapists running each track. This allows for separate programs in each track. Clinically justifiable innovations are routinely introduced into the program usually in a stepwise fashion in one or another part by one set of therapists at a time. We will assess relative impact of SPARC A and SPARC B on depressive symptoms and suicide ideation. Our investigation will allow us to assess whether this innovation is effective. Patients will not be randomized at the individual level, but rather their time slot (usually decided based on opening within the program) will place them into either SPARC A or SPARC B.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 2, 2018

First Posted

May 17, 2018

Study Start

November 14, 2017

Primary Completion

March 7, 2019

Study Completion

June 1, 2019

Last Updated

November 1, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations